| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Body Fat Small Decrease | Improves (the measure goes down) | Small effect | 1 study | 92 people | ||
| Weight | Improves (the measure goes down) | 1 study | 92 people | |||
| Body Mass Index (BMI) | Improves (the measure goes down) | 92 people | ||||
| Hip Circumference | Improves (the measure goes down) | 92 people | ||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 92 people | ||||
| Muscle Mass | Improves (the measure goes up) | 92 people | ||||
| Waist circumference | Improves (the measure goes down) | 92 people | ||||
| Waist-Hip Ratio | Improves (the measure goes up) | 92 people |
Supplement
Probiotics are live bacteria and yeasts that join the microbes in your gut, helping with digestion, the intestinal lining, and immune signaling. People most often look at them for H. pylori infection, where the evidence is strong and abdominal pain improved, and trials also found diarrhea symptoms eased in acute gastroenteritis. That diarrhea evidence is moderate, drawn from four studies of about 1,100 people, some of them children or people on chemotherapy.
Sources: PMID 39993479; PMID 40535538
- Updated
- How we grade
- 59 studies cited
- Best evidence
- Grade A
- Conditions studied
- 47
- Outcomes
- 215
- Graded outcomes
- 310915
Evidence by condition
- Strong
- Moderate
- Limited
- Very limited
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Appetite Moderate Increase | Worsens (the measure goes up) | Moderate effect | 227 people | |||
| Diarrhea Symptoms | Improves (the measure goes down) | 4 studies | 327 people | |||
Studies that measured diarrhea symptoms
| ||||||
| Mucositis Symptoms | Improves (the measure goes down) | 2 studies | 1,055 people | |||
Studies that measured mucositis symptoms | ||||||
| Weight | Improves (the measure goes down) | 1 study | 1,089 people | |||
| Bloating | Improves (the measure goes down) | 125 people | ||||
| Constipation Signs and Symptoms | Improves (the measure goes down) | 142 people | ||||
| Quality of Life | Improves (the measure goes up) | 1,089 people | ||||
H. Pylori Infection
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Abdominal Pain Moderate Improvement | Improves (the measure goes down) | Moderate effect | 5,036 people | |||
| Diarrhea Symptoms | Improves (the measure goes down) | 4 studies | 5,036 people | |||
Studies that measured diarrhea symptoms
| ||||||
| Helicobacter Pylori Infection Signs | Improves (the measure goes up) | 2 studies | 3,707 people | |||
Studies that measured helicobacter pylori infection signs | ||||||
| Adverse Events | Improves (the measure goes down) | 2,413 people | ||||
| Bloating | Improves (the measure goes down) | 5,036 people | ||||
| Constipation Signs and Symptoms | Improves (the measure goes down) | 5,036 people | ||||
| Nausea Symptoms | Improves (the measure goes down) | 5,036 people | ||||
| Vomiting | Improves (the measure goes down) | 5,036 people | ||||
H. Pylori Infection
- Abdominal Pain: improves
- Diarrhea Symptoms: changes; see studies
- Helicobacter Pylori Infection Signs: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Abdominal Pain Moderate Improvement | Improves (the measure goes down) | Moderate effect | 5,036 people | |||
| Diarrhea Symptoms | Changes; see studies | 4 studies | 5,036 people | |||
Studies that measured diarrhea symptoms
| ||||||
| Helicobacter Pylori Infection Signs | Improves (the measure goes up) | 2 studies | 3,707 people | |||
Studies that measured helicobacter pylori infection signs | ||||||
| Adverse Events | Changes; see studies | 2,413 people | ||||
| Bloating | Changes; see studies | 5,036 people | ||||
| Constipation Signs and Symptoms | Changes; see studies | 5,036 people | ||||
| Nausea Symptoms | Changes; see studies | 5,036 people | ||||
| Vomiting | Changes; see studies | 5,036 people | ||||
Alzheimer’s Disease
- Cognition
- Attention
- Memory: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Cognition Mixed effect | 4 studies | 419 people | ||||
Studies that measured cognition
| ||||||
| Attention No effect | NoneNo effect | 402 people | ||||
| Memory | Improves (the measure goes up) | 517 people | ||||
Acute Gastroenteritis
- Diarrhea Symptoms: improves
- Fever: improves
- Vomiting: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Diarrhea Symptoms Moderate Improvement | Improves (the measure goes down) | Moderate effect | 4 studies | 1,125 people | ||
Studies that measured diarrhea symptoms
| ||||||
| Fever | Improves (the measure goes up) | 134 people | ||||
| Vomiting | Improves (the measure goes down) | 980 people | ||||
Asthma
- Asthma Symptoms: improves
- Lung Function: improves
- Immunoglobulin A: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Asthma Symptoms Small Improvement | Improves (the measure goes down) | Small effect | 2 studies | 544 people | ||
| Lung Function | Improves (the measure goes up) | 1 study | 438 people | |||
| Immunoglobulin A | Improves (the measure goes up) | 362 people | ||||
| Immunoglobulin E | Improves (the measure goes up) | 372 people | ||||
| Interleukin 4 | Improves (the measure goes up) | 665 people | ||||
Coronary Artery Disease (CAD)
- C-Reactive Protein (CRP)
- Glutathione (GSH): improves
- Nitric Oxide: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| C-Reactive Protein (CRP) Mixed effect | 2 studies | 164 people | ||||
| Glutathione (GSH) | Improves (the measure goes up) | 120 people | ||||
| Nitric Oxide | Improves (the measure goes up) | 120 people | ||||
| Oxidative Stress Biomarkers | Improves (the measure goes down) | 164 people | ||||
| Total Antioxidant Capacity (TAC) | Improves (the measure goes up) | 120 people | ||||
Psoriasis
- C-Reactive Protein (CRP)
- Psoriasis Symptoms: improves
- Interleukin 6: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| C-Reactive Protein (CRP) Mixed effect | 2 studies | 400 people | ||||
| Psoriasis Symptoms | Improves (the measure goes down) | 1 study | 400 people | |||
Studies that measured psoriasis symptoms | ||||||
| Interleukin 6 | Improves (the measure goes down) | 400 people | ||||
| Quality of Life | Improves (the measure goes up) | 400 people | ||||
Metabolic Health
- Blood glucose: improves
- HbA1c: improves
- Insulin Resistance: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood glucose Small Improvement | Improves (the measure goes down) | Small effect | 1 study | 450 people | ||
| HbA1c | Improves (the measure goes down) | 2 studies | 671 people | |||
Studies that measured hba1c
| ||||||
| Insulin Resistance | Improves (the measure goes down) | 1 study | 389 people | |||
Studies that measured insulin resistance | ||||||
| Testosterone | Improves (the measure goes up) | 1 study | 47 people | |||
| Total cholesterol | Improves (the measure goes down) | 1 study | 363 people | |||
| Blood Pressure | Improves (the measure goes down) | 306 people | ||||
| Body Mass Index (BMI) | Improves (the measure goes down) | 363 people | ||||
| Follicle-Stimulating Hormone | Improves (the measure goes up) | 47 people | ||||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 433 people | ||||
| Insulin | Changes; see studies | 424 people | ||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 433 people | ||||
| Luteinizing Hormone | Improves (the measure goes up) | 47 people | ||||
| Sex Hormone Binding Globulin | Improves (the measure goes up) | 47 people | ||||
| Thyroid-Stimulating Hormone | Improves (the measure goes up) | 47 people | ||||
| Triglycerides | Improves (the measure goes down) | 433 people | ||||
Menopause
- Menopausal Symptoms: improves
- Vaginal Dryness: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Menopausal Symptoms Small Improvement | Improves (the measure goes down) | Small effect | 1 study | 462 people | ||
Studies that measured menopausal symptoms | ||||||
| Vaginal Dryness | Improves (the measure goes up) | 462 people | ||||
General Cardiovascular Health
- Blood glucose: improves
- HbA1c: improves
- Insulin Resistance: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood glucose Small Improvement | Improves (the measure goes down) | Small effect | 1 study | 450 people | ||
| HbA1c | Improves (the measure goes down) | 2 studies | 671 people | |||
Studies that measured hba1c
| ||||||
| Insulin Resistance | Improves (the measure goes down) | 1 study | 389 people | |||
Studies that measured insulin resistance | ||||||
| Total cholesterol | Improves (the measure goes down) | 1 study | 363 people | |||
| Blood Pressure | Improves (the measure goes down) | 306 people | ||||
| Body Mass Index (BMI) | Improves (the measure goes down) | 363 people | ||||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 433 people | ||||
| Insulin | Changes; see studies | 424 people | ||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 433 people | ||||
| Triglycerides | Improves (the measure goes down) | 433 people | ||||
Irritable Bowel Syndrome (IBS)
- Abdominal Pain: improves
- Bloating: improves
- Irritable Bowel Syndrome Symptoms: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Abdominal Pain Moderate Improvement | Improves (the measure goes down) | Moderate effect | 2,359 people | |||
| Bloating | Improves (the measure goes down) | 702 people | ||||
| Irritable Bowel Syndrome Symptoms | Improves (the measure goes down) | 6,732 people | ||||
| Quality of Life | Improves (the measure goes up) | 732 people |
Colorectal Cancer
- Bloating
- Diarrhea Symptoms: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Bloating Mixed effect | 344 people | |||||
| Diarrhea Symptoms | Improves (the measure goes down) | 4 studies | 408 people |
Stress
- Cognition
- Sleep Quality: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Cognition Mixed effect | 4 studies | 44 people | ||||
| Sleep Quality | Improves (the measure goes up) | 1 study | 55 people |
Depression
- Depression Symptoms: improves
- Sleep Quality: improves
- Sleep Duration: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Depression Symptoms Small Improvement | Improves (the measure goes down) | Small effect | 1 study | 140 people | ||
| Sleep Quality | Improves (the measure goes up) | 1 study | 424 people | |||
| Sleep Duration | Improves (the measure goes up) | 226 people | ||||
| Sleep Efficiency | Improves (the measure goes up) | 166 people | ||||
| Sleep Latency | Improves (the measure goes down) | 226 people |
Insomnia
- Depression Symptoms: improves
- Sleep Quality: improves
- Sleep Duration: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Depression Symptoms Small Improvement | Improves (the measure goes down) | Small effect | 1 study | 140 people | ||
| Sleep Quality | Improves (the measure goes up) | 1 study | 424 people | |||
| Sleep Duration | Improves (the measure goes up) | 226 people | ||||
| Sleep Efficiency | Improves (the measure goes up) | 166 people | ||||
| Sleep Latency | Improves (the measure goes down) | 226 people |
Nonalcoholic Fatty Liver Disease (NAFLD)
- Blood glucose: improves
- HbA1c: improves
- Insulin Resistance: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood glucose Small Improvement | Improves (the measure goes down) | Small effect | 1 study | 899 people | ||
| HbA1c | Improves (the measure goes down) | 2 studies | 899 people | |||
| Insulin Resistance | Improves (the measure goes down) | 1 study | 2,820 people | |||
| Total cholesterol | Improves (the measure goes down) | 1 study | 2,820 people | |||
| Body Mass Index (BMI) | Improves (the measure goes down) | 1,921 people | ||||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 2,820 people | ||||
| Insulin | Changes; see studies | 899 people | ||||
| Liver Enzymes | Changes; see studies | 2,820 people | ||||
| Liver Fat | Improves (the measure goes down) | 1,921 people | ||||
| Liver Fibrosis | Improves (the measure goes down) | 1,921 people | ||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 2,820 people | ||||
| TNF-Alpha | Improves (the measure goes down) | 899 people | ||||
| Triglycerides | Improves (the measure goes down) | 2,820 people |
Overweight
- Body Fat: improves
- Total cholesterol: improves
- Weight: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Body Fat Small Decrease | Improves (the measure goes down) | Small effect | 1 study | 92 people | ||
| Total cholesterol | Improves (the measure goes down) | 1 study | 92 people | |||
| Weight | Improves (the measure goes down) | 1 study | 422 people | |||
| Body Mass Index (BMI) | Improves (the measure goes down) | 244 people | ||||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 92 people | ||||
| Hip Circumference | Improves (the measure goes down) | 92 people | ||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 412 people | ||||
| Muscle Mass | Improves (the measure goes up) | 92 people | ||||
| Visceral Fat | Improves (the measure goes down) | 231 people | ||||
| Waist circumference | Improves (the measure goes down) | 297 people | ||||
| Waist-Hip Ratio | Improves (the measure goes up) | 92 people |
Weight Loss & Maintenance
- Body Fat: improves
- Total cholesterol: improves
- Weight: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Body Fat Small Decrease | Improves (the measure goes down) | Small effect | 1 study | 92 people | ||
| Total cholesterol | Improves (the measure goes down) | 1 study | 92 people | |||
| Weight | Improves (the measure goes down) | 1 study | 422 people | |||
| Body Mass Index (BMI) | Improves (the measure goes down) | 244 people | ||||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 92 people | ||||
| Hip Circumference | Improves (the measure goes down) | 92 people | ||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 412 people | ||||
| Muscle Mass | Improves (the measure goes up) | 92 people | ||||
| Visceral Fat | Improves (the measure goes down) | 231 people | ||||
| Waist circumference | Improves (the measure goes down) | 297 people | ||||
| Waist-Hip Ratio | Improves (the measure goes up) | 92 people |
Type 2 Diabetes
- Blood glucose: improves
- HbA1c: improves
- Insulin Resistance: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood glucose Small Improvement | Improves (the measure goes down) | Small effect | 1 study | 1,920 people | ||
| HbA1c | Improves (the measure goes down) | 2 studies | 1,920 people | |||
| Insulin Resistance | Improves (the measure goes down) | 1 study | 1,920 people | |||
| Insulin | Changes; see studies | 1,920 people |
Body Composition
- Body Fat: improves
- Weight: improves
- Body Mass Index (BMI): improves
Diabetic Retinopathy
- Blood glucose: improves
- C-Reactive Protein (CRP): improves
- HbA1c: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Blood glucose Small Improvement | Improves (the measure goes down) | Small effect | 1 study | 55 people | ||
| C-Reactive Protein (CRP) | Improves (the measure goes down) | 2 studies | 55 people | |||
| HbA1c | Improves (the measure goes down) | 2 studies | 55 people | |||
| Insulin Resistance | Improves (the measure goes down) | 1 study | 55 people | |||
| Diabetic Retinopathy Symptoms | Improves (the measure goes down) | 55 people | ||||
| Glutathione (GSH) | Improves (the measure goes up) | 55 people | ||||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 55 people | ||||
| Insulin | Changes; see studies | 55 people | ||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 55 people | ||||
| Total Antioxidant Capacity (TAC) | Improves (the measure goes up) | 55 people |
Hair Loss
- Hair Regrowth
- Microbiome: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Hair Regrowth No effect | NoneNo effect | 2 studies | 219 people | |||
| Microbiome | Improves (the measure goes up) | 115 people |
Preeclampsia
- All-Cause Mortality
- Pre-Eclampsia Risk: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| All-Cause Mortality No effect | NoneNo effect | 1 study | 7,735 people | |||
| Pre-Eclampsia Risk | Changes; see studies | 7,735 people |
Obesity
- Body Mass Index (BMI)
- Depression Symptoms: improves
- Weight: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Body Mass Index (BMI) No effect | NoneNo effect | 244 people | ||||
| Depression Symptoms | Improves (the measure goes down) | 1 study | 488 people | |||
| Weight | Improves (the measure goes down) | 1 study | 422 people | |||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 412 people | ||||
| Visceral Fat | Improves (the measure goes down) | 231 people | ||||
| Waist circumference | Improves (the measure goes down) | 297 people |
Cystic Fibrosis
- Cystic Fibrosis Symptoms
- Fecal Calprotectin: improves
- Lung Function: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Cystic Fibrosis Symptoms No effect | NoneNo effect | 258 people | ||||
| Fecal Calprotectin | Improves (the measure goes up) | 1 study | 177 people | |||
| Lung Function | Improves (the measure goes up) | 1 study | 284 people | |||
| Quality of Life | Improves (the measure goes up) | 37 people |
Eczema (Atopic Dermatitis)
- Allergic Disease Risk
- Eczema Symptoms: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Allergic Disease Risk No effect | NoneNo effect | 399 people | ||||
| Eczema Symptoms | Improves (the measure goes down) | 1 study | 440 people |
Migraine Headache
- Migraine Duration
- Migraine Frequency: improves
- Migraine Severity: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Migraine Duration No effect | NoneNo effect | 120 people | ||||
| Migraine Frequency | Improves (the measure goes down) | 120 people | ||||
| Migraine Severity | Improves (the measure goes down) | 120 people |
Osteoarthritis (OA)
- Body Mass Index (BMI)
- C-Reactive Protein (CRP): improves
- Osteoarthritis Symptoms: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Body Mass Index (BMI) No effect | NoneNo effect | 129 people | ||||
| C-Reactive Protein (CRP) | Improves (the measure goes down) | 2 studies | 563 people | |||
| Osteoarthritis Symptoms | Improves (the measure goes down) | 1 study | 627 people | |||
| Pain | Improves (the measure goes down) | 562 people |
Hormone Health
- Follicle-Stimulating Hormone
- HbA1c: improves
- Testosterone: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Follicle-Stimulating Hormone No effect | NoneNo effect | 47 people | ||||
| HbA1c | Improves (the measure goes down) | 2 studies | 47 people | |||
| Testosterone | Improves (the measure goes up) | 1 study | 47 people | |||
| Total cholesterol | Improves (the measure goes down) | 1 study | 47 people | |||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 47 people | ||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 47 people | ||||
| Luteinizing Hormone | Improves (the measure goes up) | 47 people | ||||
| Sex Hormone Binding Globulin | Improves (the measure goes up) | 47 people | ||||
| Thyroid-Stimulating Hormone | Improves (the measure goes up) | 47 people | ||||
| Triglycerides | Improves (the measure goes down) | 47 people |
Metabolic Syndrome
- Body Mass Index (BMI)
- Weight: improves
- Low-density lipoprotein (LDL): improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Body Mass Index (BMI) No effect | NoneNo effect | 244 people | ||||
| Weight | Improves (the measure goes down) | 1 study | 422 people | |||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 412 people | ||||
| Visceral Fat | Improves (the measure goes down) | 231 people | ||||
| Waist circumference | Improves (the measure goes down) | 297 people |
Mild Cognitive Impairment (MCI)
- Attention
- Cognition: improves
- Memory: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Attention No effect | NoneNo effect | 402 people | ||||
| Cognition | Improves (the measure goes up) | 4 studies | 419 people | |||
| Memory | Improves (the measure goes up) | 517 people |
Prediabetes
- Beta-cell function
- HbA1c: improves
- Blood glucose: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Beta-cell function No effect | NoneNo effect | 153 people | ||||
| HbA1c | Improves (the measure goes down) | 2 studies | 567 people | |||
| Blood glucose | Improves (the measure goes down) | 1 study | 576 people | |||
| Insulin Resistance | Improves (the measure goes down) | 1 study | 515 people | |||
| Total cholesterol | Improves (the measure goes down) | 1 study | 253 people | |||
| Blood Pressure | Improves (the measure goes down) | 432 people | ||||
| High-density lipoprotein (HDL) | Improves (the measure goes up) | 323 people | ||||
| Insulin | Changes; see studies | 550 people | ||||
| Low-density lipoprotein (LDL) | Improves (the measure goes down) | 323 people | ||||
| Triglycerides | Improves (the measure goes down) | 323 people |
Food Allergy
- Allergic Disease Risk
- Eczema Symptoms: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Allergic Disease Risk No effect | NoneNo effect | 399 people | ||||
| Eczema Symptoms | Improves (the measure goes down) | 1 study | 440 people |
Malnutrition
- Height
- Weight: changes; see studies
- Lower Respiratory Tract Infection Risk: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Height No effect | NoneNo effect | 530 people | ||||
| Weight | Changes; see studies | 1 study | 562 people | |||
| Lower Respiratory Tract Infection Risk | Changes; see studies | 3,086 people |
Alzheimer’s Disease
- Attention
- Cognition: improves
- Memory: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Attention No effect | NoneNo effect | 402 people | ||||
| Cognition | Improves (the measure goes up) | 4 studies | 419 people | |||
| Memory | Improves (the measure goes up) | 517 people |
Autism Spectrum Disorder (ASD)
- Autism Symptoms: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Autism Symptoms | Improves (the measure goes down) | 3 studies | 480 people |
Head and Neck Cancer
- Mucositis Symptoms: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Mucositis Symptoms | Improves (the measure goes down) | 2 studies | 691 people |
Schizophrenia
- C-Reactive Protein (CRP): improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| C-Reactive Protein (CRP) | Improves (the measure goes down) | 2 studies | 239 people |
Radiation Therapy Side-Effects
- Mucositis Symptoms: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Mucositis Symptoms | Improves (the measure goes down) | 2 studies | 1,055 people |
Bacterial Vaginosis (BV)
- Bacterial Vaginosis Symptoms: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Bacterial Vaginosis Symptoms | Improves (the measure goes down) | 1 study | 1,662 people |
Bone Health
- Bone Mineral Density: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Bone Mineral Density | Improves (the measure goes up) | 1 study | 479 people |
Cognitive Improvement
- Serum BDNF: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Serum BDNF | Improves (the measure goes up) | 1 study | 2,372 people |
Pregnancy and Delivery Health
- Gestational Diabetes Risk: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Gestational Diabetes Risk | Changes; see studies | 1 study | 3,527 people |
Vaginal Health
- Vaginal Infection Risk: changes; see studies
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Vaginal Infection Risk | Changes; see studies | 1 study | 100 people |
Gingivitis
- Dental Health Metrics: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Dental Health Metrics | Improves (the measure goes up) | 1 study | 951 people |
Periodontitis
- Dental Health Metrics: improves
| Grade | Outcome | Effect | Size | Studies | People | Studies list |
|---|---|---|---|---|---|---|
| Dental Health Metrics | Improves (the measure goes up) | 1 study | 951 people |
What the published studies found
9 automated readings
LDL cholesterol
The best available review (2026, 28 studies) found an improvement in LDL cholesterol. That review studied individuals with overweight and obesity. 6 of the 8 studies read agree; 2 found no clear difference. The evidence is moderate.
8 studies counted of 8 read: 7 reviews and 1 trial (50 people in the trials).
- Meta-analysis, 2026; 28 studies; individuals with overweight and obesity: improves (the review the verdict rests on).
LDL (MD = -0.06 mmol/L; 95% CI: -0.12, -0.01)
Effect of Probiotic and Symbiotic Supplementation on Lipid Parameters in Individuals With Overweight and Obesity: A Systematic Review and Meta-Analysis - Meta-analysis, 2024; 11 studies; overweight or obese women: improves. Impact of probiotics on weight loss, glucose and lipid metabolism in overweight or obese women: A meta-analysis of randomized controlled trials
- Meta-analysis, 2023; 40 studies, 2,795 people; patients with cardiometabolic risk factors: improves. The effect of probiotic and synbiotic supplementation on lipid parameters among patients with cardiometabolic risk factors: a systematic review and meta-analysis of clinical trials
- Meta-analysis, 2021; 39 studies, 2,237 people: improves.
reductions in blood low-density lipoprotein cholesterol (LDL-C)
The effect of probiotic fermented milk products on blood lipid concentrations: A systematic review and meta-analysis of randomized controlled trials - Meta-analysis, 2018; 10 studies; pregnant women, including those with gestational diabetes mellitus: no clear difference.
low density lipoprotein cholesterol (LDL-c) (OR -0.38
The effects of probiotics supplementation on metabolic health in pregnant women: An evidence based meta-analysis - Meta-analysis, 2017; 15 studies, 976 people: improves. Effect of probiotic Lactobacillus on lipid profile: A systematic review and meta-analysis of randomized, controlled trials
- Meta-analysis, 2015; 15 studies, 788 people: improves. Effects of probiotics consumption on lowering lipids and CVD risk factors: a systematic review and meta-analysis of randomized controlled trials
- Randomised trial, 2026; 50 people; women with polycystic ovary syndrome: no clear difference.
No statistically significant between-group differences were detected
More than Hormones? Metabolic Effects of Twelve-Week Probiotic Supplementation in Women with Polycystic Ovary Syndrome: A Secondary Analysis of a Randomized Double-Blind Placebo-Controlled Study
- Meta-analysis, 2026; 28 studies; individuals with overweight and obesity: improves (the review the verdict rests on).
Bloating
The best available review (2013, 37 studies) found an improvement in bloating. That review studied adults with lower gastrointestinal symptoms. 5 of the 7 studies read agree; 2 found no clear difference. The evidence is moderate.
7 studies counted of 11 read: 4 reviews and 3 trials (500 people in the trials).
- Systematic review, 2013; 37 studies; adults with lower gastrointestinal symptoms: improves (the review the verdict rests on).
reduce bloating/distension and improve bowel movement frequency/consistency in some IBS patients
Systematic review: probiotics in the management of lower gastrointestinal symptoms in clinical practice -- an evidence-based international guide - Systematic review, 2026; patients with irritable bowel syndrome: improves.
probiotics can modestly improve global symptoms, abdominal pain, and bloating in IBS
Clinical guidance and practical recommendations for probiotic use in patients with irritable bowel syndrome, functional constipation, and Clostridioides difficile infection considering sex-based differences: a Korean translation - Meta-analysis, 2024; 23 studies, 3,288 people: improves. Efficacy of Probiotics in the Management of Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis
- Meta-analysis, 2022; 13 studies; healthy adults: no clear difference.
No improvement in abdominal pain and bloating was found.
Effects of Bifidobacterium animalis subspecies lactis supplementation on gastrointestinal symptoms: systematic review with meta-analysis - Randomised trial, 2026; 350 people; healthy individuals with self-reported bloating or indigestion: improves.
Bloating and gas were reduced in the synbiotic arm
A Randomized, Placebo-Controlled Trial Evaluating Multi-Species Synbiotic Supplementation for Bloating, Gas, and Abdominal Discomfort - Crossover trial, 2026; 25 people; healthy adults: no clear difference. A high-fibre snack containing Lacticaseibacillus rhamnosus GG for healthy adults: a randomised, double-blind, placebo-controlled crossover trial
- Randomised trial, 2023; 125 people; patients with functional abdominal bloating: improves.
patients in the probiotic group had a significantly lower frequency of abdominal bloating
Evaluation and comparison of therapeutic effects of probiotics and colloidal bismuth subcitrate on abdominal bloating
- Systematic review, 2013; 37 studies; adults with lower gastrointestinal symptoms: improves (the review the verdict rests on).
Blood pressure
The studies disagree. A Cochrane review (2025, 17 studies, 838 people) did not settle it for blood pressure, while 7 of the 10 studies read found an improvement. The evidence is very weak.
10 studies counted of 10 read: 10 reviews.
- Systematic review, 2025; 17 studies, 838 people; children and adolescents with overweight or obesity: unclear: evidence too weak to tell (the review the verdict rests on).
Probiotics compared to placebo may have little to no effect on
Gut microbiome-based interventions for the management of obesity in children and adolescents aged up to 19 years - Meta-analysis, 2026; 17 studies, 1,281 people; adults with prediabetes and type 2 diabetes mellitus: improves.
significantly reduction in both systolic BP
Effects of Probiotics and Synbiotics Supplementation on Blood Pressure in Adults with Prediabetes and Type 2 Diabetes Mellitus: A Grade-Assessed Systematic Review and Dose-Response Meta-Analysis - Meta-analysis, 2025; 26 studies, 1,755 people; overweight and obese adults: improves.
beneficial effect on systolic blood pressure
The Effects of Probiotics Consumption on Blood Pressure, Lipid Profile, Glycemic Indices, and Inflammatory Parameters in Overweight and Obese Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials - Systematic review, 2022; 5 studies, 250 people; solid organ transplant recipients: unclear: evidence too weak to tell.
Probiotics had uncertain effects on GI side effects, infection rates immediately post-transplant, liver function, blood …
Synbiotics, prebiotics and probiotics for solid organ transplant recipients - Systematic review, 2020; 5 studies, 2,703 people; hypertensive adults with or without type 2 diabetes: improves.
moderate effect of probiotics on BP in hypertensive adults
Effect of probiotic foods and supplements on blood pressure: a systematic review of meta-analyses studies of controlled trials - Meta-analysis, 2020; 14 studies, 846 people; patients with hypertension: improves.
significant reduction in SBP by - 2.05 mmHg
Effects of Probiotics on Patients with Hypertension: a Systematic Review and Meta-Analysis - Meta-analysis, 2020; 7 studies, 653 people: no clear difference. Effect of Lactobacillusplantarum containing probiotics on blood pressure: A systematic review and meta-analysis
- Meta-analysis, 2020; 32 studies; patients with type 2 diabetes mellitus: improves.
significant effect of probiotics on reducing
Probiotics have beneficial metabolic effects in patients with type 2 diabetes mellitus: a meta-analysis of randomized clinical trials - Meta-analysis, 2018; 11 studies, 641 people; adults with type II diabetes: improves.
significantly decreased SBP (WMD, -3.28 mmHg
Probiotic supplementation for management of cardiovascular risk factors in adults with type II diabetes: A systematic review and meta-analysis - Meta-analysis, 2014; 9 studies: improves.
significantly changed systolic BP by -3.56 mm Hg
Effect of probiotics on blood pressure: a systematic review and meta-analysis of randomized, controlled trials
- Systematic review, 2025; 17 studies, 838 people; children and adolescents with overweight or obesity: unclear: evidence too weak to tell (the review the verdict rests on).
Gastrointestinal symptoms
The studies disagree. A Cochrane review (2022, 5 studies, 250 people) did not settle it for gastrointestinal symptoms, while 8 of the 10 studies read found an improvement. The evidence is very weak.
10 studies counted of 11 read: 6 reviews and 4 trials (161 people in the trials).
- Systematic review, 2022; 5 studies, 250 people; solid organ transplant recipients: unclear: evidence too weak to tell (the review the verdict rests on).
Probiotics had uncertain effects on GI side effects
Synbiotics, prebiotics and probiotics for solid organ transplant recipients - Systematic review, 2026; 15 studies, 1,015 people; individuals with autism spectrum disorder: improves.
improvements in GI symptoms, such as reduced abdominal pain
Pre- and probiotics for gastrointestinal and behavioral symptoms in autism spectrum disorder: a systematic review - Meta-analysis, 2026; 28 studies; patients with Helicobacter pylori infection: improves. Evaluating probiotic monotherapy in Helicobacter pylori infection: A meta-analysis of randomized controlled trials with trial sequential analysis
- Meta-analysis, 2026; 12 studies; adults with colorectal cancer receiving chemotherapy: improves.
significantly reduced chemotherapy-related diarrhea (odds ratio 0.48
Comparative Effects of Microbiota-Modifying Interventions for Gastrointestinal Disorders in Adults with Colorectal Cancer: A Systematic Review and Network Meta-Analysis - Meta-analysis, 2025; 18 studies, 1,246 people: improves.
alleviated gastrointestinal disturbances, such as diarrhea
Research progress of probiotics intervention on reconstruction of intestinal flora and improvement of quality of life in patients after endometrial cancer surgery - Meta-analysis, 2015; 23 studies, 3,938 people; children receiving antibiotics: improves.
incidence of AAD in the probiotic group was 8%
Probiotics for the prevention of pediatric antibiotic-associated diarrhea - Randomised trial, 2025; 59 people; overweight and obese adults aged 20-40: improves.
alleviated symptoms such as gastroesophageal reflux
Impact of probiotic Lactobacillus plantarum GKM3 on gastrointestinal health in overweight and obese individuals: A randomized clinical trial - Randomised trial, 2025; 22 people; patients with irritable bowel syndrome with predominant diarrhea: improves. Colonoscopic administration of probiotics to treat irritable bowel syndrome with predominant diarrhea: a randomized placebo-controlled clinical trial
- Randomised trial, 2025; 16 people; female dancers: no clear difference.
No improvement in gastrointestinal symptoms was observed
A Randomized Controlled Trial Evaluating the Effects of a Probiotic Containing Lactobacillus helveticus R0052 and Bifidobacterium longum R0175 on Gastrointestinal Symptoms and Metabolomic Profiles in Female Dancers - Randomised trial, 2017; 64 people; patients receiving aspirin for more than one month: improves.
FSSG and GSRS scores were also significantly improved
Yogurt Containing Lactobacillus gasseri Mitigates Aspirin-Induced Small Bowel Injuries: A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial
- Systematic review, 2022; 5 studies, 250 people; solid organ transplant recipients: unclear: evidence too weak to tell (the review the verdict rests on).
Irritable bowel syndrome symptoms
A Cochrane review (2023, 18 studies, 1,309 people) found a large improvement in irritable bowel syndrome symptoms. That review studied children with functional abdominal pain disorders. 9 of the 11 studies read agree; 1 found no clear answer, 1 found no clear difference. The evidence is limited.
11 studies counted of 11 read: 11 reviews.
- Meta-analysis, 2023; 18 studies, 1,309 people; children with functional abdominal pain disorders: improves (the review the verdict rests on).
Probiotics may achieve more treatment success when compared with placebo
Probiotics for management of functional abdominal pain disorders in children - Meta-analysis, 2026; 12 studies, 1,303 people; patients with irritable bowel syndrome: improves.
Multistrain probiotics significantly reduced total IBS-SSS scores [mean difference = -43.66, 95% confidence interval (CI): …
Effect of multistrain probiotics on symptom severity in irritable bowel syndrome: a systematic review and meta-analysis of irritable bowel syndrome-symptom severity score outcomes - Meta-analysis, 2025; 16 studies, 2,823 people: improves.
Probiotics showed a clinically significant overall improvement
Efficacy of Specific Probiotic Strains in Subtypes of Irritable Bowel Syndrome: Systematic Review and Meta-Analysis of Randomized Controlled Trials - Systematic review, 2025; 44 studies; patients with irritable bowel syndrome: improves.
significantly lower effectiveness than the probiotics group
Effects of Probiotics and Diet Management in Patients With Irritable Bowel Syndrome: A Systematic Review and Network Meta-analysis - Meta-analysis, 2024; 23 studies, 3,288 people: improves. Efficacy of Probiotics in the Management of Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis
- Meta-analysis, 2024; 20 studies, 3,011 people: improves.
probiotics are more effective than placebo in reducing global IBS symptoms improvement rate
Efficacy and safety of probiotics in irritable bowel syndrome: A systematic review and meta-analysis - Meta-analysis, 2023; 72 studies; people with irritable bowel syndrome: improves.
significantly better overall effect of probiotics than placebo
Probiotics for the management of irritable bowel syndrome: a systematic review and three-level meta-analysis - Meta-analysis, 2022; 16 studies, 1,585 people; patients with diarrhea: improves. Meta-analysis of the efficacy of probiotics to treat diarrhea
- Meta-analysis, 2018; 53 studies, 5,545 people; adults with irritable bowel syndrome: unclear: evidence too weak to tell.
beneficial effects on global IBS symptoms and abdominal pain
Systematic review with meta-analysis: the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome - Meta-analysis, 2017; 19 studies, 1,453 people; children with recurrent abdominal pain or irritable bowel syndrome: improves.
probiotics were more likely to experience improvement in pain
Dietary interventions for recurrent abdominal pain in childhood - Systematic review, 2009; 2 studies, 168 people; school-age children with recurrent abdominal pain: no clear difference. Dietary interventions for recurrent abdominal pain (RAP) and irritable bowel syndrome (IBS) in childhood
- Meta-analysis, 2023; 18 studies, 1,309 people; children with functional abdominal pain disorders: improves (the review the verdict rests on).
Memory
The best available review (2026, 21 studies) found an improvement in memory. That review studied people across the human lifespan. 6 of the 8 studies read agree; 1 found no clear answer, 1 found no clear difference. The evidence is moderate.
8 studies counted of 9 read: 5 reviews and 3 trials (242 people in the trials).
- Meta-analysis, 2026; 21 studies; people across the human lifespan: improves (the review the verdict rests on). Effects of probiotics on cognitive function across the human lifespan: a meta-analysis
- Systematic review, 2025; 39 studies; animal models and humans: unclear: evidence too weak to tell.
consistently improved spatial learning, working memory
Early-life cognitive effects of prebiotics and probiotics: A cross-species systematic review - Meta-analysis, 2024; 12 studies, 852 people; adults with mild cognitive impairment or Alzheimer's disease: improves.
recall/delayed memory (SMD=0.67; 95% CI: 0.32, 1.02)
Effect of probiotics on cognitive function in adults with mild cognitive impairment or Alzheimer's disease: A meta-analysis of randomized controlled trials - Meta-analysis, 2023; 10 studies, 702 people; older adults with cognitive impairment: improves. Evaluation of improvement of cognitive impairment in older adults with probiotic supplementation: A systematic review and meta-analysis
- Systematic review, 2016; 38 studies; animals and humans: improves. Effect of Probiotics on Central Nervous System Functions in Animals and Humans: A Systematic Review
- Randomised trial, 2022; 59 people; healthy young adults: no clear difference.
There were no effects on cognitive performance or mental health. Evidence in favor of the …
Effects of a multi-strain probiotic on hippocampal structure and function, cognition, and emotional well-being in healthy individuals: a double-blind randomised-controlled trial - Randomised trial, 2020; 80 people; older adults with suspected mild cognitive impairment: improves.
significant improvement in domain scores of immediate memory
Probiotic Bifidobacterium breve in Improving Cognitive Functions of Older Adults with Suspected Mild Cognitive Impairment: A Randomized, Double-Blind, Placebo-Controlled Trial - Randomised trial, 2019; 103 people; stressed adults with moderate stress: improves.
enhanced memory and cognitive traits such as social emotional cognition
Probiotic Lactobacillus plantarum P8 alleviated stress and anxiety while enhancing memory and cognition in stressed adults: A randomised, double-blind, placebo-controlled study
Respiratory infections
A Cochrane review (2022, 24 studies, 6,950 people) found a small improvement in respiratory infections. That review studied people of all ages at risk of acute URTIs. 6 of the 7 studies read agree; 1 found no clear answer. The evidence is limited.
7 studies counted of 10 read: 6 reviews and 1 trial (120 people in the trials).
- Systematic review, 2022; 24 studies, 6,950 people; people of all ages at risk of acute URTIs: improves (the review the verdict rests on).
probiotics may reduce the number of participants diagnosed with URTIs
Probiotics for preventing acute upper respiratory tract infections - Systematic review, 2026; 8 studies, 1,158 people; children with respiratory tract infections: improves. Comparative efficacy and safety of probiotic for respiratory tract infections in children: a network meta-analysis
- Meta-analysis, 2026; 32 studies; patients with upper respiratory tract infections: unclear: evidence too weak to tell.
pooled incidence reduction was non-significant (RD = -0.07
The Efficacy of Probiotics in Treating Upper Respiratory Tract Infections, Allergic Rhinitis, and Chronic Rhinosinusitis: A Systematic Review and Meta-Analysis - Meta-analysis, 2025; 13 studies; patients with respiratory diseases: improves.
significantly reduced the incidence of respiratory disease episodes
Role of Lacticaseibacillus rhamnosus GG in the Management of Respiratory Diseases: A Systematic Review and Meta-Analysis - Meta-analysis, 2019; 17 studies, 3,488 people; children aged up to 18 years: improves. Probiotics for preventing acute otitis media in children
- Meta-analysis, 2014; 8 studies, 1,083 people; ICU patients receiving mechanical ventilation: improves.
use of probiotics decreased the incidence of VAP
Probiotics for preventing ventilator-associated pneumonia - Randomised trial, 2026; 120 people; children with recurrent respiratory tract infections: improves.
Probiotics significantly improved clinical efficacy compared with placebo
Probiotic modulation of gut microbiota with Bifidobacterium animalis subsp. lactis XLTG11 and Lactobacillus plantarum CCFM8661 mitigates recurrent respiratory infections in children: a randomised-controlled trial
- Systematic review, 2022; 24 studies, 6,950 people; people of all ages at risk of acute URTIs: improves (the review the verdict rests on).
Sleep quality
The best available review (2025, 6 studies, 424 people) found an improvement in sleep quality. That review studied patients with insomnia. 7 of the 8 studies read agree; 1 found no clear answer. The evidence is moderate.
8 studies counted of 11 read: 7 reviews and 1 trial.
- Systematic review, 2025; 6 studies, 424 people; patients with insomnia: improves (the review the verdict rests on).
significant reduction in Pittsburgh Sleep Quality Index (PSQI)
Impact of probiotics on sleep quality and mood states in patients with insomnia: a systematic review and meta-analysis - Systematic review, 2026; 13 studies, 890 people; adults, healthy and poor sleep quality: improves.
probiotic supplementation significantly reduced PSQI scores
Association between probiotic intervention and sleep quality in the general adult population: a systematic review and meta-analysis - Systematic review, 2026; 19 studies, 762 people: improves.
Overall, probiotic intake appears to modify resting state connectivity and activity, decrease involvement of several …
The effects of oral probiotic intervention on brain structure and function in human adults: a systematic review - Meta-analysis, 2024; 15 studies: improves.
PSQI) scores in the probiotics group was significantly lower
Effects of probiotics on sleep parameters: A systematic review and meta-analysis - Systematic review, 2024; 11 studies; adults with sleep disorders or sub-healthy sleep conditions: improves.
improves sleep states to some extent
Effect of probiotics and paraprobiotics on patients with sleep disorders and sub-healthy sleep conditions: a meta-analysis of randomized controlled trials - Meta-analysis, 2023; 18 studies: unclear: evidence too weak to tell.
not demonstrated to be associated with significant improvement in sleep quality
Effect of gut microbiota modulation on sleep: a systematic review and meta-analysis of clinical trials - Meta-analysis, 2023; people with sleep disturbances: improves.
probiotics supplementation significantly reduced the self-assessed parameter
Microbiota Composition and Probiotics Supplementations on Sleep Quality-A Systematic Review and Meta-Analysis - Randomised trial, 2024; healthy adults under mild stress aged 18-35 years: improves.
exhibited significant improvements in wearable device- measured sleep duration
Lacticaseibacillus paracasei 207-27 alters the microbiota-gut-brain axis to improve wearable device-measured sleep duration in healthy adults: a randomized, double-blind, placebo-controlled trial
- Systematic review, 2025; 6 studies, 424 people; patients with insomnia: improves (the review the verdict rests on).
Stress
The best available review (2026, 12 studies, 3,350 people) found a small improvement in stress. That review studied healthy working adults. All 4 studies read agree. The evidence is moderate.
4 studies counted of 11 read: 3 reviews and 1 trial (75 people in the trials).
- Meta-analysis, 2026; 12 studies, 3,350 people; healthy working adults: improves (the review the verdict rests on).
statistically significant positive effect on subclinical psychological outcomes
Probiotic intake and mental health in healthy working adults: a systematic review and meta-analysis of randomized controlled trials - Systematic review, 2026; 6 studies, 180 people; exercised individuals and athletes: improves.
occasional reductions in stress, anxiety, and fatigue
The effect of probiotic and synbiotic supplementation on sleep parameters in exercised population: a systematic review and synthesis without meta-analysis (SWiM) of randomized controlled trials - Meta-analysis, 2020; 11 studies, 577 people: improves.
probiotic supplementation increased total antioxidant capacity (TAC)
The Effects of Supplementation with Probiotic on Biomarkers of Oxidative Stress in Adult Subjects: a Systematic Review and Meta-analysis of Randomized Trials - Randomised trial, 2026; 75 people; healthy older adults aged 55-70: improves.
showing a significant between-group advantage over the placebo
Pediococcus acidilactici PA53 Improves Emotional Well-Being and Gut Health While Modulating Microbiota Composition in Older Adults: A Randomized, Double-Blind, Placebo-Controlled Trial
- Meta-analysis, 2026; 12 studies, 3,350 people; healthy working adults: improves (the review the verdict rests on).
Key findings
- AppetiteWorsens (the measure goes up)
- Abdominal PainImproves (the measure goes down)
- Cognition
Shop the evidence-backed picks
Fullscript collections
Fullscript collectionGut and digestion: evidence-graded picksOpen on FullscriptFullscript collectionWomen's health: evidence-graded picksOpen on FullscriptEach collection holds the supplements we grade A or B for its theme, in third-party tested products where the catalog has them. It opens in our Fullscript store. You can look through it without signing in; Fullscript asks for a free account to order.
Or shop one supplement
Third-party tested Probiotics products, in the forms the graded studies used where we can match them.
- Grade A
We earn from purchases made in our Fullscript store, and links to Fullscript, iHerb or Thorne carry our referral, so we may earn a commission at no extra cost to you. Grades come from the research and never change based on what we earn. Full disclosure
Studies cited
59 studies from PubMed
- The effects of probiotic supplementation on cardiometabolic health in patients with prediabetes: a systematic review, meta-analysis, and GRADE assessment.
- Lactococcus lactis strain Plasma activates plasmacytoid dendritic cells and mitigates common cold-like symptoms in healthy adults: a meta-analysis of individual participant data.
- Probiotics and Immune Health: Current Knowledge and Future Perspectives
- Probiotics for Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis
- Probiotics for Prevention and Treatment of Diarrhea: A Systematic Review and Meta-Analysis
- Probiotics for the Prevention and Treatment of Depression: A Systematic Review and Meta-Analysis
- Effects of Probiotics on Metabolic Syndrome: A Systematic Review of Randomized Clinical Trials
- Probiotics and Weight Loss: A Systematic Review and Meta-Analysis
- The Gut Microbiome, Probiotics, and Their Impact on Skin Health: A Review
- Health Benefits of Probiotics: A Review
- Probiotics: Comprehensive Review of Growth Promotion Mechanisms and Action in Food Products
- Probiotics: Classification, Mode of Action and Role in Human Nutrition
- Safety of Probiotics: A Comprehensive Review
- Probiotics, Prebiotics and Inflammation: A Review of the Science
- Probiotics and Healthy Ageing: A Systematic Review and Meta-Analysis
- World Gastroenterology Organisation Global Guidelines: Probiotics and Prebiotics
- Probiotics for Human Use: Current Advances and Future Perspectives
- Probiotics for people with cystic fibrosis.
- Probiotics for the prevention of gestational diabetes mellitus: A meta-analysis of randomized controlled trials.
- The effects of probiotics supplements on metabolic indices and clinical signs in patients with diabetic retinopathy, a randomized double blind clinical trial.
- Effect of applying Lactiplantibacillus plantarum subsp. plantarum N793 to the scalps of men and women with thinning hair: a randomized, double-blind, placebo-controlled, parallel-group study.
- Randomized Clinical Trial to Evaluate the Effect of Probiotic Intake on Androgenic Alopecia.
- Impact of probiotics on sleep quality and mood states in patients with insomnia: a systematic review and meta-analysis.
- Gaba-producing lactobacilli boost cognitive reactivity to negative mood without improving cognitive performance: A human Double-Blind Placebo-Controlled Cross-Over study.
- The effect of probiotic consumption on lipid profile, glycemic index, inflammatory markers, and liver function in NAFLD patients: A systematic review and meta-analysis of randomized controlled trials.
- Efficacy of probiotics in the treatment of oral mucositis in head and neck cancer patients: A systematic review and meta-analysis.
- The effect of probiotics on severe oral mucositis in cancer patients undergoing chemotherapy and/or radiotherapy: A meta-analysis.
- Oral probiotic supplementation to alleviate diarrhea induced by fluoropyrimidines or irinotecan-based chemotherapy: A systematic review and meta-analysis.
- The impact of probiotics on core autism symptoms - A systematic review and meta-analysis of randomized clinical trials.
- Efficacy and safety of Bacteroides fragilis BF839 for pediatric autism spectrum disorder: a randomized clinical trial.
- Probiotics for autism spectrum disorder: An updated systematic review and meta-analysis of effects on symptoms.
- The efficacy and safety of probiotics in the adjuvant treatment of psoriasis: a systematic review and meta-analysis of randomized controlled trials.
- Effects of probiotic supplementation on testosterone levels in healthy ageing men: A 12-week double-blind, placebo-controlled randomized clinical trial.
- A 12-Week, Single-Centre, Randomised, Double-Blind, Placebo-Controlled, Parallel-Design Clinical Trial for the Evaluation of the Efficacy and Safety of Lactiplantibacillus plantarum SKO-001 in Reducing Body Fat.
- Effects of oral supplementation of probiotics on body weight and visceral fat in obese patients: a meta-analysis and systematic review.
- The effects of probiotics administration during pregnancy on preeclampsia and associated maternal, fetal, and newborn outcomes: a systematic review and meta-analysis.
- Effects of probiotics supplementation on glycemic profile in adults with type 2 diabetes mellitus: A grade-assessed systematic review and dose-response meta-analysis of randomized controlled trials.
- The Effect of Probiotics on Obesity with Comorbid Depression: A Systematic Review and Meta-Analysis.
- A network meta-analysis of probiotics in the treatment of childhood asthma.
- Efficacy of probiotics as adjuvant therapy in bronchial asthma: a systematic review and meta-analysis.
- Efficacy and safety of Saccharomyces boulardii as an adjuvant therapy for the eradication of Helicobacter pylori: a meta-analysis.
- Efficacy of probiotics regimens for Helicobacter pylori eradication: A systematic review, pairwise, and network meta-analysis of randomized controlled trials.
- Effect of probiotics on C-reactive protein levels in schizophrenia: Evidence from a systematic review and meta-analysis.
- Probiotics Supplementation for Improving Glucolipid Parameters in Individuals with Prediabetes: A Systematic Review and Meta-Analysis of Randomized Trials.
- Systematic review and meta-analysis on probiotics as treatment for food allergies among pediatric patients: A 2024 update.
- Efficacy of Oral Probiotic Supplementation in Preventing Vulvovaginal Infections During Pregnancy: A Randomized and Placebo-Controlled Clinical Trial.
- Clinical effects of probiotics on the treatment of gingivitis and periodontitis: a systematic review and meta-analysis.
- Evaluation of the efficacy of probiotics in the chemoradiotherapy of colorectal cancer: a meta-analysis of Randomized Controlled Trials.
- Clinical efficacy of probiotic supplementation in the treatment of knee osteoarthritis: a meta-analysis.
- The effect of probiotics on select cognitive domains in mild cognitive impairment and Alzheimer's disease: A systematic review and meta-analysis.
- Efficacy of probiotic supplementation in influencing cognitive function in Alzheimer's disease: A systematic review and meta-analysis.
- Effectiveness of probiotic supplements on cognitive function in mild cognitive impairment and Alzheimer's disease: A meta-analysis of randomized controlled trials.
- Probiotics are a good choice for the treatment of bacterial vaginosis: a meta-analysis of randomized controlled trial
- Efficacy and safety of Saccharomyces boulardii CNCM I-745 for the treatment of pediatric acute diarrhea in China: a systematic review and meta-analysis.
- Efficacy of probiotics in reducing the duration and severity of acute gastroenteritis in children: A meta-analysis of randomized controlled trials.
- Investigating the effects of probiotics during the menopause transition: A systematic review & meta-analysis.
- Effects of probiotic supplements on bone mineral density and bone turnover markers in postmenopausal women: A systematic review.
- Impact of probiotic supplementation on serum levels of brain-derived neurotrophic factor: GRADE-based dose-response meta-analysis.
- Probiotic Supplementation and Inflammatory Status in Coronary Artery Disease: A Systematic Review and Meta-Analysis.